Screening and Treatment of Infections Caused by Resistant Enterococci

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1991 Feb 1

PMID 2024952

Citations 13

Authors

D J Herman

D N Gerding

Affiliations

Soon will be listed here.

Citing Articles

Phenotypic and Genotypic Analysis of Bacterial Pathogens Recovered from Patients Diagnosed with Fever of Unknown Origin in Egypt.

Mostafa S, Saleh S, Khaleel E, Mustafa Badi R, Aboshanab K, Hamed S Antibiotics (Basel). 2023; 12(8).

PMID: 37627714 PMC: 10451874. DOI: 10.3390/antibiotics12081294.

High-level Aminoglycoside Resistance and Reduced Susceptibility to Vancomycin in Nosocomial Enterococci.

Adhikari L J Glob Infect Dis. 2010; 2(3):231-5.

PMID: 20927283 PMC: 2946678. DOI: 10.4103/0974-777X.68534.

Vancomycin-resistant enterococci.

Cetinkaya Y, Falk P, Mayhall C Clin Microbiol Rev. 2000; 13(4):686-707.

PMID: 11023964 PMC: 88957. DOI: 10.1128/CMR.13.4.686.

Resistant enterococci--mechanisms, laboratory detection and control in hospitals.

Wade J, Uttley A J Clin Pathol. 1996; 49(9):700-3.

PMID: 9038751 PMC: 500716. DOI: 10.1136/jcp.49.9.700.

Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.

Whitman M, Pitsakis P, DeJesus E, Osborne A, Levison M, Johnson C Antimicrob Agents Chemother. 1996; 40(6):1526-30.

PMID: 8726031 PMC: 163361. DOI: 10.1128/AAC.40.6.1526.

References

Ryan R, Kwasnik I, Tilton R . Methodological variation in antibiotic synergy tests against enterococci. J Clin Microbiol. 1981; 13(1):73-5. PMC: 273724. DOI: 10.1128/jcm.13.1.73-75.1981. View

Courvalin P, Carlier C, Collatz E . Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J Bacteriol. 1980; 143(2):541-51. PMC: 294311. DOI: 10.1128/jb.143.2.541-551.1980. View

Matsumoto J, Wilson W, Wright A, GERACI J, Washington 2nd J . Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis. Antimicrob Agents Chemother. 1980; 18(6):944-7. PMC: 352994. DOI: 10.1128/AAC.18.6.944. View

Eliopoulos G, Moellering Jr R . Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside. Antimicrob Agents Chemother. 1981; 19(5):789-93. PMC: 181523. DOI: 10.1128/AAC.19.5.789. View

Kaye D . Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility. Arch Intern Med. 1982; 142(11):2006-9. DOI: 10.1001/archinte.142.11.2006. View

Wright A, Wilson W, Matsumoto J, Washington 2nd J, GERACI J . Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis. Antimicrob Agents Chemother. 1982; 22(6):972-5. PMC: 185703. DOI: 10.1128/AAC.22.6.972. View

Farber B, Moellering Jr R . Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother. 1983; 23(1):138-41. PMC: 184631. DOI: 10.1128/AAC.23.1.138. View

Moellering Jr R, WENNERSTEN C . Therapeutic potential of rifampin in enterococcal infections. Rev Infect Dis. 1983; 5 Suppl 3:S528-32. DOI: 10.1093/clinids/5.supplement_3.s528. View

Scheld W, Keeley J . Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis. J Antimicrob Chemother. 1983; 12 Suppl D:65-78. DOI: 10.1093/jac/12.suppl_d.65. View

10.

Wilson W, Wilkowske C, Wright A, Sande M, GERACI J . Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med. 1984; 100(6):816-23. DOI: 10.7326/0003-4819-100-6-816. View

11.

Eliopoulos G, Farber B, Murray B, WENNERSTEN C, Moellering Jr R . Ribosomal resistance of clinical enterococcal to streptomycin isolates. Antimicrob Agents Chemother. 1984; 25(3):398-9. PMC: 185531. DOI: 10.1128/AAC.25.3.398. View

12.

Ikeda D, Barry A, Andersen S . Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides. Diagn Microbiol Infect Dis. 1984; 2(3):171-7. DOI: 10.1016/0732-8893(84)90027-0. View

13.

Goodhart G . In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall. JAMA. 1984; 252(19):2748-9. View

14.

Indrelie J, Wilson W, Matsumoto J, GERACI J, Washington 2nd J . Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother. 1984; 26(6):909-12. PMC: 180048. DOI: 10.1128/AAC.26.6.909. View

15.

Sullam P, Tauber M, Hackbarth C, Sande M . Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1985; 27(1):135-6. PMC: 176220. DOI: 10.1128/AAC.27.1.135. View

16.

Dickinson G, Rodriguez K, Arcey S, Alea A, GREENMAN R . Efficacy of imipenem/cilastatin in endocarditis. Am J Med. 1985; 78(6A):117-21. DOI: 10.1016/0002-9343(85)90113-5. View

17.

Moody J, Peterson L, Gerding D . In vitro activity of ciprofloxacin combined with azlocillin. Antimicrob Agents Chemother. 1985; 28(6):849-50. PMC: 180346. DOI: 10.1128/AAC.28.6.849. View

18.

Williamson R, Gutmann L, Horaud T, Delbos F, Acar J . Use of penicillin-binding proteins for the identification of enterococci. J Gen Microbiol. 1986; 132(7):1929-37. DOI: 10.1099/00221287-132-7-1929. View

19.

Henry N, Wilson W, GERACI J . Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin. Antimicrob Agents Chemother. 1986; 30(5):725-8. PMC: 176521. DOI: 10.1128/AAC.30.5.725. View

20.

Thauvin C, Eliopoulos G, Willey S, WENNERSTEN C, Moellering Jr R . Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother. 1987; 31(2):139-43. PMC: 174678. DOI: 10.1128/AAC.31.2.139. View